• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寨卡病毒 NS5 蛋白的结构与功能:药物设计的视角。

Structure and function of Zika virus NS5 protein: perspectives for drug design.

机构信息

Department of Biochemistry, University of California, Riverside, CA, 92521, USA.

Department of Microbiology and Plant Pathology , University of California, Riverside, CA, 92521, USA.

出版信息

Cell Mol Life Sci. 2018 May;75(10):1723-1736. doi: 10.1007/s00018-018-2751-x. Epub 2018 Feb 8.

DOI:10.1007/s00018-018-2751-x
PMID:29423529
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5911220/
Abstract

Zika virus (ZIKV) belongs to the positive-sense single-stranded RNA-containing Flaviviridae family. Its recent outbreak and association with human diseases (e.g. neurological disorders) have raised global health concerns, and an urgency to develop a therapeutic strategy against ZIKV infection. However, there is no currently approved antiviral against ZIKV. Here we present a comprehensive overview on recent progress in structure-function investigation of ZIKV NS5 protein, the largest non-structural protein of ZIKV, which is responsible for replication of the viral genome, RNA capping and suppression of host interferon responses. Structural comparison of the N-terminal methyltransferase domain and C-terminal RNA-dependent RNA polymerase domain of ZIKV NS5 with their counterparts from related viruses provides mechanistic insights into ZIKV NS5-mediated RNA replication, and identifies residues critical for its enzymatic activities. Finally, a collection of recently identified small molecule inhibitors against ZIKV NS5 or its closely related flavivirus homologues are also discussed.

摘要

Zika 病毒(ZIKV)属于正链单链 RNA 含有的黄病毒科。其最近的爆发以及与人类疾病(如神经紊乱)的关联引发了全球健康关注,并迫切需要开发针对 ZIKV 感染的治疗策略。然而,目前还没有针对 ZIKV 的批准抗病毒药物。本文对 Zika 病毒非结构蛋白 5(ZIKV NS5)的结构-功能研究进展进行了全面综述,ZIKV NS5 是 ZIKV 中最大的非结构蛋白,负责病毒基因组的复制、RNA 加帽和抑制宿主干扰素反应。ZIKV NS5 的 N 端甲基转移酶结构域和 C 端 RNA 依赖的 RNA 聚合酶结构域与相关病毒的对应结构域的结构比较为 ZIKV NS5 介导的 RNA 复制提供了机制见解,并确定了对其酶活性至关重要的残基。最后,还讨论了最近鉴定的针对 ZIKV NS5 或其密切相关的黄病毒同源物的小分子抑制剂。

相似文献

1
Structure and function of Zika virus NS5 protein: perspectives for drug design.寨卡病毒 NS5 蛋白的结构与功能:药物设计的视角。
Cell Mol Life Sci. 2018 May;75(10):1723-1736. doi: 10.1007/s00018-018-2751-x. Epub 2018 Feb 8.
2
Zika Virus Methyltransferase: Structure and Functions for Drug Design Perspectives.寨卡病毒甲基转移酶:药物设计视角下的结构与功能
J Virol. 2017 Feb 14;91(5). doi: 10.1128/JVI.02202-16. Print 2017 Mar 1.
3
NS5 from Dengue Virus Serotype 2 Can Adopt a Conformation Analogous to That of Its Zika Virus and Japanese Encephalitis Virus Homologues.登革热病毒 2 型 NS5 可采用与寨卡病毒和日本脑炎病毒同源物类似的构象。
J Virol. 2019 Dec 12;94(1). doi: 10.1128/JVI.01294-19.
4
Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.非核苷类 Zika 病毒 RNA 依赖性 RNA 聚合酶抑制剂。
J Virol. 2020 Oct 14;94(21). doi: 10.1128/JVI.00794-20.
5
Optimal flexibility of the linker region of Zika virus NS5 methyltransferase-polymerase is critical for virus replication.寨卡病毒 NS5 甲基转移酶-聚合酶连接区的最佳灵活性对病毒复制至关重要。
Antiviral Res. 2021 Nov;195:105194. doi: 10.1016/j.antiviral.2021.105194. Epub 2021 Oct 23.
6
A cell-based assay to discover inhibitors of Zika virus RNA-dependent RNA polymerase.一种用于发现寨卡病毒RNA依赖性RNA聚合酶抑制剂的基于细胞的检测方法。
Virology. 2024 Jan;589:109939. doi: 10.1016/j.virol.2023.109939. Epub 2023 Nov 11.
7
The crystal structure of Zika virus NS5 reveals conserved drug targets.寨卡病毒NS5的晶体结构揭示了保守的药物靶点。
EMBO J. 2017 Apr 3;36(7):919-933. doi: 10.15252/embj.201696241. Epub 2017 Mar 2.
8
Identification of Novel Non-Nucleoside Inhibitors of Zika Virus NS5 Protein Targeting MTase Activity.鉴定靶向 Zika 病毒 NS5 蛋白甲基转移酶活性的新型非核苷抑制剂。
Int J Mol Sci. 2024 Feb 19;25(4):2437. doi: 10.3390/ijms25042437.
9
Structure of the NS5 methyltransferase from Zika virus and implications in inhibitor design.寨卡病毒NS5甲基转移酶的结构及其在抑制剂设计中的意义。
Biochem Biophys Res Commun. 2017 Oct 28;492(4):624-630. doi: 10.1016/j.bbrc.2016.11.098. Epub 2016 Nov 17.
10
Supramolecular arrangement of the full-length Zika virus NS5.全长 Zika 病毒 NS5 的超分子排列。
PLoS Pathog. 2019 Apr 5;15(4):e1007656. doi: 10.1371/journal.ppat.1007656. eCollection 2019 Apr.

引用本文的文献

1
Animal Models, Therapeutics, and Vaccine Approaches to Emerging and Re-Emerging Flaviviruses.针对新出现和再次出现的黄病毒的动物模型、治疗方法及疫苗策略
Viruses. 2024 Dec 24;17(1):1. doi: 10.3390/v17010001.
2
Ubiquitin-like modifier-activating enzyme 1 interacts with Zika virus NS5 and promotes viral replication in the infected cell.泛素样修饰激活酶1与寨卡病毒NS5相互作用并促进病毒在感染细胞中的复制。
J Gen Virol. 2025 Jan;106(1). doi: 10.1099/jgv.0.002063.
3
E2 Ubiquitin-Conjugating Enzymes Regulates Dengue Virus-2 Replication in .E2泛素结合酶调节登革病毒2型在……中的复制 。 (原文句子不完整)
Microorganisms. 2024 Dec 5;12(12):2508. doi: 10.3390/microorganisms12122508.
4
Etravirine Prevents West Nile Virus and Chikungunya Virus Infection Both In Vitro and In Vivo by Inhibiting Viral Replication.依曲韦林通过抑制病毒复制在体外和体内预防西尼罗河病毒和基孔肯雅病毒感染。
Pharmaceutics. 2024 Aug 23;16(9):1111. doi: 10.3390/pharmaceutics16091111.
5
Recent advances in the study of zika virus structure, drug targets, and inhibitors.寨卡病毒结构、药物靶点及抑制剂研究的最新进展
Front Pharmacol. 2024 Jul 1;15:1418516. doi: 10.3389/fphar.2024.1418516. eCollection 2024.
6
The ZIKV NS5 Protein Aberrantly Alters the Tubulin Cytoskeleton, Induces the Accumulation of Autophagic p62 and Affects IFN Production: HDAC6 Has Emerged as an Anti-NS5/ZIKV Factor.寨卡病毒 NS5 蛋白异常改变微管细胞骨架,诱导自噬 p62 积累并影响 IFN 产生:HDAC6 已成为抗 NS5/寨卡病毒因子。
Cells. 2024 Mar 29;13(7):598. doi: 10.3390/cells13070598.
7
A conformational selection mechanism of flavivirus NS5 for species-specific STAT2 inhibition.黄病毒 NS5 对种属特异性 STAT2 抑制的构象选择机制。
Commun Biol. 2024 Jan 10;7(1):76. doi: 10.1038/s42003-024-05768-8.
8
African ZIKV lineage fails to sustain infectivity in an in vitro mimetic urban cycle.非洲寨卡病毒谱系在体外模拟城市循环中无法维持感染力。
Braz J Microbiol. 2023 Sep;54(3):1421-1431. doi: 10.1007/s42770-023-01053-8. Epub 2023 Jul 17.
9
Repurposing of Doramectin as a New Anti-Zika Virus Agent.多杀菌素再利用作为一种新的抗寨卡病毒药物。
Viruses. 2023 Apr 27;15(5):1068. doi: 10.3390/v15051068.
10
Evolution of Antiretroviral Drug Rilpivirine and Approach to Oncology.抗逆转录病毒药物利匹韦林的演变和肿瘤学方法。
Int J Mol Sci. 2023 Feb 2;24(3):2890. doi: 10.3390/ijms24032890.

本文引用的文献

1
Nuclear import inhibitor N-(4-hydroxyphenyl) retinamide targets Zika virus (ZIKV) nonstructural protein 5 to inhibit ZIKV infection.核输入抑制剂N-(4-羟基苯基)视黄酰胺靶向寨卡病毒(ZIKV)非结构蛋白5以抑制ZIKV感染。
Biochem Biophys Res Commun. 2017 Dec 2;493(4):1555-1559. doi: 10.1016/j.bbrc.2017.10.016. Epub 2017 Oct 4.
2
Cell-line dependent antiviral activity of sofosbuvir against Zika virus.细胞系依赖性索非布韦抗寨卡病毒的抗病毒活性。
Antiviral Res. 2017 Oct;146:161-163. doi: 10.1016/j.antiviral.2017.09.004. Epub 2017 Sep 11.
3
Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae.索非布韦可保护 Zika 病毒感染的小鼠免于死亡,预防短期和长期后遗症。
Sci Rep. 2017 Aug 25;7(1):9409. doi: 10.1038/s41598-017-09797-8.
4
Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice.利巴韦林可抑制 Zika 病毒(ZIKV)在体外的复制,并抑制 STAT1 缺陷型 ZIKV 感染小鼠的病毒血症。
Antiviral Res. 2017 Oct;146:1-11. doi: 10.1016/j.antiviral.2017.08.007. Epub 2017 Aug 14.
5
Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication.病毒聚合酶抑制剂T-705和T-1105是寨卡病毒复制的潜在抑制剂。
Arch Virol. 2017 Sep;162(9):2847-2853. doi: 10.1007/s00705-017-3436-8. Epub 2017 Jun 8.
6
Inhibitors compounds of the flavivirus replication process.黄病毒复制过程的抑制剂化合物。
Virol J. 2017 May 15;14(1):95. doi: 10.1186/s12985-017-0761-1.
7
Development of a S-adenosylmethionine analog that intrudes the RNA-cap binding site of Zika methyltransferase.开发一种腺苷甲硫氨酸类似物,该类似物能侵入寨卡甲基转移酶的 RNA 帽结合位点。
Sci Rep. 2017 May 9;7(1):1632. doi: 10.1038/s41598-017-01756-7.
8
Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond.用于黄病毒感染的广谱药物:登革热、寨卡病毒及其他。
Nat Rev Drug Discov. 2017 Aug;16(8):565-586. doi: 10.1038/nrd.2017.33. Epub 2017 May 5.
9
TAM Receptors Are Not Required for Zika Virus Infection in Mice.寨卡病毒感染小鼠不需要TAM受体。
Cell Rep. 2017 Apr 18;19(3):558-568. doi: 10.1016/j.celrep.2017.03.058.
10
AXL is not essential for Zika virus infection in the mouse brain.AXL对寨卡病毒在小鼠大脑中的感染并非必不可少。
Emerg Microbes Infect. 2017 Mar 29;6(3):e16. doi: 10.1038/emi.2017.10.